| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.005 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.0051 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |